The antisense homology box: A new motif within proteins that encodes biologically active peptides
暂无分享,去创建一个
M. Boros | H. Okada | Lajos Baranyi | William Campbell | Hidechika Okada | L. Baranyi | Kunihiro Ohshima | Seigo Fujimoto | MiháLy Boros | W. Campbell | Kunihiro Ohshima | S. Fujimoto
[1] K. Bost,et al. Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[2] S. Nakanishi,et al. Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.
[3] R. Parthasarathy,et al. A model for hydropathy-based peptide interactions. , 1989, Archives of biochemistry and biophysics.
[4] Y. Shai,et al. Antisense peptide recognition of sense peptides: sequence simplification and evaluation of forces underlying the interaction. , 1989, Biochemistry.
[5] A Tropsha,et al. Making sense from antisense: A review of experimental data and developing ideas on sense–antisense peptide recognition , 1992, Journal of molecular recognition : JMR.
[6] A. Moffat. Making sense of antisense. , 1991, Science.
[7] K. Bost,et al. Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[8] D. Webb,et al. Endothelin: progress in pharmacology and physiology. , 1993, Trends in pharmacological sciences.
[9] Blalock Je. Complementarity of peptides specified by «sense» and «antisense» strands of DNA , 1990 .
[10] V. Mooser,et al. Vasopressin antisense peptide interactions with the V1 receptor , 1990, Peptides.
[11] K. Bost,et al. Production of anti‐idiotypic antibodies by immunization with a pair of complementary peptides , 1989, Journal of molecular recognition : JMR.
[12] R. Brentani,et al. Characterization of the cellular receptor for fibronectin through a hydropathic complementarity approach. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[13] G. Moore,et al. Angiotensin 'antipeptides': (-)messenger RNA complementary to human angiotensin II (+)messenger RNA encodes an angiotensin receptor antagonist. , 1989, Biochemical and biophysical research communications.
[14] J. Blalock,et al. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[15] K. Bost,et al. An antibody to a peptide specified by an RNA that is complementary to γ-endorphin mRNA recognizes an opiate receptor , 1986, Journal of Neuroimmunology.
[16] A D Olson,et al. Recognition properties of peptides hydropathically complementary to residues 356-375 of the c-raf protein. , 1989, The Journal of biological chemistry.
[17] Brenda L. Bass,et al. A developmentally regulated activity that unwinds RNA duplexes , 1987, Cell.
[18] H. Johnson,et al. A novel arginine vasopressin-binding peptide that blocks arginine vasopressin modulation of immune function. , 1988, Journal of Immunology.
[19] M. Sokolovsky. Endothelins and sarafotoxins: receptor heterogeneity. , 1994, The International journal of biochemistry.
[20] A. Doherty,et al. Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. , 1992, Biochemical and biophysical research communications.
[21] W. Neidhart,et al. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist , 1993, Nature.
[22] S. Siegel,et al. Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.
[23] R. Brentani,et al. Determination of the putative binding site for fibronectin on platelet glycoprotein IIb-IIIa complex through a hydropathic complementarity approach. , 1989, The Journal of biological chemistry.
[24] A. Eberle,et al. Antisense peptides: tools for receptor isolation? Lack of antisense MSH and ACTH to interact with their sense peptides and to induce receptor-specific antibodies. , 1991, Journal of receptor research.
[25] K. Nakao,et al. Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists. , 1993, The Journal of biological chemistry.
[26] K. Draper. Self-complementary regions in human albumin mRNA encode important structural regions within the human albumin protein. , 1989, Biochemical and biophysical research communications.
[27] V. Castronovo,et al. Laminin receptor complementary DNA-deduced synthetic peptide inhibits cancer cell attachment to endothelium. , 1991, Cancer research.
[28] D. Melton,et al. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity , 1987, Cell.
[29] J. Grassi,et al. Antipeptide Polyclonal Antibodies that Recognize a Substance P‐Binding Site in Mammalian Tissues: A Biochemical and Immunocytochemical Study , 1994, Journal of neurochemistry.
[30] G. Fassina,et al. Design of hydropathically complementary peptides for Big Endothelin affinity purification. , 2009, International journal of peptide and protein research.
[31] E. Benveniste,et al. Monoclonal idiotypic and anti-idiotypic antibodies produced by immunization with peptides specified by a region of human myelin basic protein mRNA and its complement , 1989, Journal of Neuroimmunology.
[32] The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. , 1991, Biochemical and biophysical research communications.
[33] K. Ebner,et al. Interactions of antisense peptides with ovine prolactin. , 1991, Biochemical and biophysical research communications.
[34] H. Morris,et al. Mass spectrometry of natural and recombinant proteins and glycoproteins , 1988 .
[35] V. P. Knutson. Insulin-binding peptide. Design and characterization. , 1988, Journal of Biological Chemistry.
[36] D. Brutlag,et al. Is there a relationship between DNA sequences encoding peptide ligands and their receptors? , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[37] V. Kon,et al. Endothelin and cyclosporine nephrotoxicity. , 1992, Renal failure.
[38] T. Sakurai,et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.
[39] Y. Yazaki,et al. Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. , 1992, Gerontology.
[40] J. Zull,et al. Is genetic code redundancy related to retention of structural information in both DNA strands? , 1990, Trends in biochemical sciences.
[41] K. P. Murphy,et al. Molecular basis of co-operativity in protein folding. , 1992, Journal of molecular biology.
[42] R. Seckler,et al. Protein folding and protein refolding , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] K. Bost,et al. Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin-2 and their respective receptors. , 1985, Biochemical and biophysical research communications.
[44] U. Rasmussen,et al. On antisense peptides: the parathyroid hormone as an experimental example and a critical theoretical view. , 1987, Biochemical and biophysical research communications.
[45] J. Whitaker,et al. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies. , 1993, Journal of immunology.
[46] N. Aiyar,et al. Affinity capture of [Arg8]vasopressin-receptor complex using immobilized antisense peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[47] K. Bost,et al. Monoclonal antibody against a peptide specified by [Met]-enkephalin complementary RNA recognizes the delta-class opioid receptor. , 1989, Immunology letters.
[48] M. Zamai,et al. Sequence-directed recognition peptides: inhibition of endothelin generation via a substrate-depletion mechanism. , 1993, Biochimica et biophysica acta.
[49] E. M. Smith,et al. Hydropathic anti-complementarity of amino acids based on the genetic code. , 1984, Biochemical and biophysical research communications.
[50] S. Whitebread,et al. Are the antibodies to a peptide complementary to angiotensin II useful to isolate the angiotensin II receptor? , 1989, The Biochemical journal.
[51] J. Blalock,et al. Characterization and localization of mosquito‐gut receptors for trypsin modulating oostatic factor using a complementary peptide and immunocytochemistry , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] T. K. Gartner,et al. The Peptide Glu-His-IIe-Pro-Ala Binds Fibrinogen and Inhibits Platelet Aggregation and Adhesion to Fibrinogen and Vitronectin , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[53] E. Escher,et al. The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action. , 1989, The Biochemical journal.
[54] K. Bost,et al. Immunoaffinity‐purified opiate receptor specifically binds the δ‐class opiate receptor ligand, cis‐(+)‐3‐methylfentanylisothiocyanate, SUPERFIT , 1987, FEBS letters.
[55] E. Kaiser,et al. Secondary structures of proteins and peptides in amphiphilic environments. (A review). , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Campbell-Thompson,et al. Complementary peptide to the carboxyl-terminal tetrapeptide of gastrin. , 1992, Gastroenterology.
[57] S. Oparil,et al. Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[58] L. V. von Segesser,et al. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. , 1994, Circulation.
[59] W. Reiher,et al. The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. , 1986, Biochemical and biophysical research communications.
[60] Y. Liu,et al. A novel acetylcholine receptor-related peptide blocks canine cardiac ganglia and inhibits the nicotinic receptor of PC-12 cells. , 1992, Journal of the autonomic nervous system.
[61] G. Viscomi,et al. Purification of recombinant human interferon-β by immobilized antisense peptides , 1992 .
[62] P. Y. Chou,et al. Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. , 1974, Biochemistry.
[63] S. Thorgeirsson,et al. Sequence Directed Design of Recognition Peptides , 1989 .
[64] J. Leoni,et al. Binding of cystatin C to C4: the importance of sense-antisense peptides in their interaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[65] M. Campbell-Thompson,et al. Canine parietal cell binding by antibodies to the complementary peptide of somatostatin. , 1993, The American journal of the medical sciences.
[66] J. Blalock,et al. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. , 1988, Science.